Lawsuits Have Been Filed After Tests Show Triple the Allowable Levels of NDMA in Antacid drugs
One tablet of acid-reflux medication can be the cancer equivalent of smoking a carton or more of cigarettes
Wednesday, April 8, 2020 - Lawsuits are being filed seeking real monetary damages by those who through no fault of their own have developed cancer from taking certain over the counter heartburn, acid reflux, and antacid medications. Ranitidine is a chemical compound that is given to laboratory test animals to induce tumors. Well-known brands such as Prilosec, Zantac, Prevacid, Nexium, and generic Zantac have been suspected by the US Food and Drug Administration (FDA) to cause stomach cancer and pending the results of an investigation have been removed from sale by drug store giants Walmart, Walgreens, Rite Aid, and CVS. Nearly 150 lawsuits were recently filed and are being considered for consolidation in multi-district litigation in West Palm Beach Florida against these companies after ranitidine, a potentially cancer-causing substance was found in the heartburn drugs. U.S. District Judge Robin L. Rosenberg will determine, according to Raw Story.com, the extent of the malfeasance on the part of the manufacturers of the drug for bringing a faulty and dangerous drug to market as well as if the claims are similar enough to warrant consolidation. Multidistrict litigation is preferred to streamline multiple trials rather than repeat standardized procedures like discovery and scientific evidence that is not in dispute. Attorneys to Raw Story that they anticipate the number of potential plaintiffs to approach 100,000 in the months to come. For more information on how you can get a free consultation and for commonly asked questions and answers in regards to filing a stomach cancer lawsuit claim.
A drug testing company warned the FDA that it had found dangerously high levels (three times the FDA limit) of " N-nitrosodimethylamine, or NDMA, a highly toxic carcinogen." Plaintiff lawyer, South Florida's Michael Citron compared the amount of the carcinogen in heartburn medication to that of smoking. "One 100 milligram standard tablet of Zantac 75 can be the equivalent of smoking 30 packs of cigarettes."
Valisure pharmacy is an ingenious startup pharmacy company that tests medications they sell and often when the FDA falls short as is the case in acid-reflux drugs, and whose testing has set off the firestorm of litigation. The Valisure homepage highlights the company's unique marketing angle. "We sell the same (medications_ that all American pharmacies use, but first put the batches through rigorous chemical analysis so the bad batches are screened out. We summarize our analytics in an easy-to-understand certificate of analysis specific to that batch. We are the only pharmacy to do this." According to the website the company's routine testing uncovered a link between NDMA, a known carcinogen, and Zantac, the leading antiacid medication and immediately notified the FDA of their recommendation to recall the drug. Valisure's tests have been confirmed by researchers at Stanford University and others. Repeated use of popular antiacid medications could bioaccumulate unacceptably high levels of the carcinogen NDMA in the human body and certainly cause cancer. Valassure's CEO David Light concluded, "There's no acceptable cancer risk for a drug like this."
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.